Загрузка страницы

Simplifying AAV Downstream Process and Product Characterization

"Simplifying AAV Downstream Process and Product Characterization: A Look at Purification and Analytical Tools." Presented by Julia Baek, PhD, Staff Specialist, Ilaria Scarfone, PhD, MBA, Field Applications Specialist, and Chantelle Gaskin, Field Applications Specialist, Thermo Fisher Scientific.

BioProcess International Ask the Expert 2021.

Видео Simplifying AAV Downstream Process and Product Characterization канала BioProcess International
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
13 января 2024 г. 0:12:48
00:50:50
Другие видео канала
PANEL DISCUSSION  Emerging Bio Therapies and Their Manufacturing ChallengesPANEL DISCUSSION Emerging Bio Therapies and Their Manufacturing ChallengesStrategies for Implementing New Technologies in an Outsourcing Environment: A Roundtable DiscussionStrategies for Implementing New Technologies in an Outsourcing Environment: A Roundtable DiscussionKey Considerations for Maximizing LV and AAV Production in Transient Transfection WorkflowsKey Considerations for Maximizing LV and AAV Production in Transient Transfection WorkflowsReducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody...Reducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody...Aseptic Filling for Gene Therapies and Next Generation Biologics Within Closed Robotic WorkcellsAseptic Filling for Gene Therapies and Next Generation Biologics Within Closed Robotic WorkcellsCRISPR Library Screens for Oncology Target DiscoveryCRISPR Library Screens for Oncology Target DiscoveryEvaluation of the "Scale-Out" Biomanufacturing Strategy from Early Clinical...Evaluation of the "Scale-Out" Biomanufacturing Strategy from Early Clinical...Exploring New and Improved Analytical Methods for Traditional and Unique ModalitiesExploring New and Improved Analytical Methods for Traditional and Unique ModalitiesMeeting Regulatory Requirements for Cell and Gene Therapy ManufacturingMeeting Regulatory Requirements for Cell and Gene Therapy ManufacturingAddressing Purification Challenges for Complex Therapeutics with Custom Chromatography ResinsAddressing Purification Challenges for Complex Therapeutics with Custom Chromatography ResinsPractical Approaches to Metals Analysis of Cell Culture MediaPractical Approaches to Metals Analysis of Cell Culture MediaThe Critical Steps for Protein Therapeutic Potency Assay DevelopmentThe Critical Steps for Protein Therapeutic Potency Assay DevelopmentDownstream Processing with Giorgio CartaDownstream Processing with Giorgio CartaChina's GMP Strategies: Dealing with Quality Management Issues, to Compete with the WestChina's GMP Strategies: Dealing with Quality Management Issues, to Compete with the WestHow to Halve the Costs of Antibody Purification?How to Halve the Costs of Antibody Purification?Translating Inhaled and Nasal Technologies for the Delivery of BiologicsTranslating Inhaled and Nasal Technologies for the Delivery of BiologicsBioprocess 101 – Cell Culture Media AnalysisBioprocess 101 – Cell Culture Media AnalysisUnderstanding Viral Clearance During Anion Exchange Chromatography by Using a Novel Design of...Understanding Viral Clearance During Anion Exchange Chromatography by Using a Novel Design of...Securing Your Manufacturing Capacity During a PandemicSecuring Your Manufacturing Capacity During a PandemicBioconjugation CMC: Successfully Executing a Complex ProcessBioconjugation CMC: Successfully Executing a Complex ProcessImproving and Intensifying Vaccine Purification By Implementing Affinity ChromatographyImproving and Intensifying Vaccine Purification By Implementing Affinity Chromatography
Яндекс.Метрика